DoJ joins two whistleblower lawsuits against Johnson & Johnson (JNJ), alleging the firm...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

DoJ joins two whistleblower lawsuits against Johnson & Johnson (JNJ), alleging the firm improperly marketed heart drug Natrecor and could have created hundreds of millions of dollars in damages. J&J could pay triple these damages if it loses the case.